2019-09-13
2019-09-13
Plenary Hall
Ballroom A
Ballroom B
Exhibit and Poster Hall
2019-09-14
2019-09-14
Plenary Hall
Ballroom A
Ballroom B
Exhibit and Poster Hall
2019-09-15
2019-09-15
Plenary Hall
Ballroom A
Ballroom B
Plenary Hall
Ballroom A
Ballroom B
Exhibit and Poster Hall
Plenary Hall
Ballroom A
Ballroom B
Exhibit and Poster Hall
Plenary Hall
Ballroom A
Ballroom B
07:30
- 08:30
Morning Session 1: MSC therapy; Rationalism vs. Empiricism; How much must we know to test therapies in patients; a Live Debate
Allan B. Dietz, PhD (Chair)
Mayo Clinic, USA
Jacques Galipeau, MD
University of Wisconsin - Madison, USA
William Faubion, MD
Mayo Clinic, USA
08:45
- 10:15
Plenary 1: Mesenchymal and Progenitor Stem Cells: Results from the Clinic and the Future of Living Drugs
Allan B. Dietz, PhD (Chair)
Mayo Clinic, USA
Donna Skerrett, MD, MS
Mesoblast, USA
Gil Van Bokkelen, PhD
Athersys, USA
Etienne Sokal, MD, PhD
Promethera, Belgium
10:45
- 12:15
Workshop 1: ISCT-NAVRMA Joint Session – Veterinary Medicine in Developing Cell-Based Therapies and Bioengineering Approach for Human Clinical Use
Daniel Weiss, MD, PhD (Chair)
University of Vermont, USA
Tracey Webb, DVM, PhD (Chair)
Colorado State University, USA
Andrew Hoffman, DVM, DVSc, DACVIM
University of Pennsylvania School of Veterinary Medicine, USA
Kyla Ortved, DVM, PhD
University of Pennsylvania School of Veterinary Medicine, USA
Dori Borjesson, BA, DVM, MPVM, PhD
UC Davis School of Veterinary Medicine, USA
10:45
- 12:15
Q&O Track 2: Managing Growth
Lynn O’Donnell, PhD (Chair)
Ohio State University, James Cancer Hospital Columbus, USA
13:45
- 15:15
Plenary 2: iPS Pluripotent Stem Cells – True Replacement Cell Therapies
Robert Deans, PhD (Chair)
BlueRock Therapeutics, USA
Dan Kauffman, MD, PhD
University of California San Diego, USA
Stephanie Protze, PhD
University of Toronto, Canada
15:30
- 17:00
Q&O Track 3: Stability
Karl Stasko, BSc, MPH (Chair)
Dana Farber Cancer Institute, USA
15:30
- 17:00
Workshop 2: ISCT Presidential Task Force – Regulatory Aspects of Unproven Cell and Gene Therapies in North America
Laertis Ikonomou, PhD (Chair)
Boston University, USA
Peter Marks, MD, PhD
Center for Biologics Evaluation and Research, FDA, USA
Lynne Boxer, DVM
Center for Veterinary Medicine, FDA, USA
Ajay Kuriyan, MD, MS
Department of Ophthalmology, University of Rochester Medical Center, USA
Kristin Matthews, PhD
Rice University's Baker Institute for Public Policy, USA
15:30
- 17:00
Workshop 3: Gene Replacement Therapy Using Adult Stem Cells
Mitch Cairo, MD (Chair)
New York Medical College, USA
Mitch Cairo, MD
New York Medical College, USA
Jeffrey Medin, PhD
Medical College of Wisconsin, USA
Paul Orchard, MD
University of Minnesota, USA
07:30
- 08:30
Q&O Track 4: Current Clinical Development Regulatory Guidance – Context and Implications
Kurt Gunter, MD (Chair)
Cell Medica Inc., USA
Peiman Hematti, MD
University of Wisconsin-Madison School of Medicine and Public Health, USA
07:30
- 08:30
Morning Session 2: Technologist Event
Lizette Caballero, BS, MLS(ASCP)CM (Chair)
UCSF Blood and Marrow Transplant Lab, USA
07:30
- 08:30
Morning Session 3: CAR-T Meet the Experts
Sarah Nikiforow, MD, PhD (Chair)
Dana-Farber Cancer Institute, USA
08:45
- 10:15
Plenary 3: Redirecting Immune Cells – T and NK cells aside from canonical CARs
Sarah Nikiforow, MD, PhD (Chair)
Dana-Farber Cancer Institute, USA
Denis-Claude Roy, MD, FRCPC
Hopital Maisonneuve-Rosemont, Canada
Lisa Butterfield, PhD
University of Pittsburgh Department of Medicine, USA
Sumithira Vasu, MBBS
Comprehensive Cancer Center, Ohio State University, USA
10:45
- 12:15
Workshop 4: Optimizing Clinical Trials in Cellular Therapy
Denis-Claude Roy, MD, FRCPC (Chair)
Hopital Maisonneuve-Rosemont, Canada
Lauralyn McIntyre, MD, MHSc, FRCPC
Ottawa Hospital Research Institute, Canada
Sarah Nikiforow, MD, PhD
Dana-Farber Cancer Institute, USA
Steven Devine, MD
CIBMTR, USA
13:45
- 15:15
Workshop 5: Engineering to Control Cell Environment during Expansion
Erika Trauzzi (Chair)
Berkeley Lights Inc., USA
James Lim, PhD
Xcell Biosciences Inc., USA
Peter Beemiller
Berkeley Lights Inc., USA
Angelo Cardoso, MD, PhD
City of Hope, USA
15:45
- 17:15
Workshop 6: CAR-T Racing: Amateurs & Rookies Looking to Contribute
Patrick Hanley, PhD (Chair)
Children’s National Health System, USA
Lizette Caballero, BS, MLS(ASCP)CM
UCSF Blood and Marrow Transplant Lab, USA
Barbara Savoldo, MD, PhD
UNC Lineberger Comprehensive Cancer Center, USA
Hema Dave, MD, MPH
Children’s National Medical Center, USA
15:45
- 17:15
Workshop 7: FDA & Other Government Agencies
Olive Sturtevant, MSc (Chair)
Dana Farber Cancer Institute, USA
15:45
- 17:15
Q&O Track 6: Strategies for instituting materials management program for cell and gene therapy products
Aisha Khan, MS, MBA (Chair)
University of Miami, USA
07:30
- 08:30
Q&O Track 7: Synchronizing CMC preparation for commercial approval with regulatory accelerators
Yong Fan, MD (Chair)
A2Z Reg Solutions, USA
Mo Heidaran, PhD
PAREXEL, USA
08:45
- 10:15
Plenary Session 4: Emerging Engineering Strategies in Regenerative Medicine
William Murphy, PhD (Chair)
University of Wisconsin Madison, USA
Stephen Badylak, DVM, PhD, MD
Institute for Regenerative Medicine (MIRM), University of Pittsburgh, USA
Timothy Kamp, MD, PhD
Stem Cell and Regenerative Medicine Center, UW-Madison, USA
Mervin Yoder, MA, MD
Indiana University School of Medicine, USA
10:45
- 12:15
Q&O Track 8: Real World Evidence
Jiwen Zheng, PhD (Chair)
Tmunity Therapeutics, USA
10:45
- 12:15
Workshop 8: CAR-T Racing: The Pro Circuit + Future Prospects
Bruce Levine, PhD (Chair)
University of Pennsylvania, USA
Rebecca Gardner, MD
Seattle Children’s Hospital, USA
Krishanu Saha, PhD
University of Wisconsin-Madison, USA
Saar Gill, MD, PhD
Perelman School of Medicine, University of Pennsylvania, USA
Select date to see events.